Fourth annual primary care scorecard released

Investment into regular access to primary care could fill the hole in the United States’ strategy to fight against chronic disease, according to the fourth annual national primary care scorecard.
The annual report was co-funded by The Physicians Foundation and the Milbank Memorial Fund, and developed by researchers at the American Academy of Family Physicians’ Robert Graham Center.
Yalda Jabbarpour, MD, medical director of the Robert Graham Center for Policy Studies and a coauthor of the scorecard report, told Healio the authors highlighted how critical primary care is to disease prevention

ADC speaker: Peritoneal dialysis seeing ‘resurgence’ in 2026

KANSAS CITY, Mo. — Practice recommendations from large dialysis organizations and government action have contributed to a resurgence in peritoneal dialysis, according to a speaker at the Annual Dialysis Conference.
In the 1970s, PD and hemodialysis were initially viewed as equivalent, and some cases suggested the peritoneal membrane could clear middle and high molecular weight toxins better than the hemodialysis membrane, according to Joanne M. Bargman, MD, FRCPC, professor of medicine at the University of Toronto and director of the peritoneal dialysis program at the University Health Network

FDA issues warning letter to Novo Nordisk for improper reporting of GLP-1 adverse events

The FDA has issued a warning letter to Novo Nordisk for violating postmarketing adverse drug experience regulations that include failure to report adverse events among patients taking GLP-1s.
In the warning letter, the FDA said it uncovered “serious violations” of postmarketing adverse drug experience regulations following an inspection conducted at company headquarters from Jan. 13, 2025, to Feb. 7, 2025. Examples of the company’s violations included patients that were taking semaglutide (Ozempic/Wegovy) or liraglutide (Victoza/Saxenda).
Violations cited in the letter included:
The FDA

Rates of cardiac arrest increase first workday after holiday

The rate of out-of-hospital cardiac arrest the first day back to work after multiday holidays was significantly higher compared with other workdays, according to data published in JAMA Network Open.
The effect was particularly pronounced among adults older than 65 years, individuals with cardiac cause and those who presented with nonshockable rhythms, researchers reported.
“Holidays represent unique periods characterized by substantial deviations from routine daily life, potentially influencing the risk of cardiovascular events. During these periods, individuals are more likely to

Vaginal estrogen not linked to recurrence of endometrial cancer

Women who previously had endometrial cancer and used vaginal estrogen therapy did not have higher risk for cancer recurrence than those who did not use vaginal hormone therapy, according to findings published in Menopause.
“This is the largest study, to our knowledge, conducted in the U.S. assessing endometrial cancer recurrence with vaginal estrogen therapy use in endometrial cancer survivors, using recent years of data,” Christine D. Hsu, PharmD, PhD, assistant professor in the department of obstetrics and gynecology at University of Texas Medical Branch in Galveston, told Healio. “The

Lithium treatment trial feasible in mild cognitive impairment

A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published in JAMA Neurology.
“The key message for clinicians is caution,” Ariel G. Gildengers, MD, professor of psychiatry at the University of Pittsburgh School of Medicine and geriatric psychiatrist at UPMC, told Healio. “Lithium is not recommended to treat mild cognitive impairment or dementia, either on-label or off-label.
“While the results were encouraging, they were not definitive, and lithium has not

Mortality risk similar with tocilizumab, rituximab in RA-ILD

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the risk for all-cause mortality when comparing tocilizumab with rituximab, according to data published in CHEST.
“The current study indicated that tocilizumab and rituximab exhibit comparable effectiveness in managing [rheumatoid arthritis-associated ILD (RA-ILD)], with similar risks of all-cause mortality, hospitalization and mechanical ventilation over a 5-year follow-up period,” Zewen Wu, MD, of the Third Hospital of Shanxi Medical University, and colleagues wrote.
In an

Burnout common but regrets are not in allergy, immunology

PHILADELPHIA — Although 41.7% of allergists and immunologists reported burnout, most of these specialists are satisfied with their career, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Percentages of women and minorities in the field also are growing, Theresa Bingemann, MD, FAAAAI, FACAAI, allergy and immunology fellowship program director at the University of Rochester Medical Center, said during her presentation.
The American Academy of Pediatrics (AAP) has been conducting workforce surveys since the 1990s, she explained.
“The goal of

Proof-of-concept shown in pig liver xenotransplantation

A patient in China with hepatocellular carcinoma survived 171 days following xenotransplantation with a genetically modified pig liver, the first evidence of the procedure’s feasibility in a living recipient, according to researchers.
The study, published in Journal of Hepatology, was conducted in 2024 by Beicheng Sun, MD, PhD, of the department of hepatobiliary surgery at The First Affiliated Hospital of Anhui Medical University in China, and colleagues, who aimed to meet a much-needed demand in the liver transplant space.
“We do not have a very good support system for liver transplantation,

VIDEO: Cell injection therapy may simplify healing corneal edema

WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Brandon D. Ayres, MD, discusses cell injection therapy for corneal transplants or endothelial disease.
“I am so excited hearing about what happens with cell injections and the simplification they may have in healing corneal edema,” Ayres, of Wills Eye Hospital and Ophthalmic Partners, told Healio.